4-imino-8,8-dimethyl-3-(naphthalen-1-yl)-5-phenyl-5,7,8,9-tetrahydro-3H-chromeno[2,3-d]pyrimidin-6(4H)-one

ID: ALA5274570

Chembl Id: CHEMBL5274570

Max Phase: Preclinical

Molecular Formula: C29H25N3O2

Molecular Weight: 447.54

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)CC(=O)C2=C(C1)Oc1ncn(-c3cccc4ccccc34)c(=N)c1C2c1ccccc1

Standard InChI:  InChI=1S/C29H25N3O2/c1-29(2)15-22(33)25-23(16-29)34-28-26(24(25)19-10-4-3-5-11-19)27(30)32(17-31-28)21-14-8-12-18-9-6-7-13-20(18)21/h3-14,17,24,30H,15-16H2,1-2H3

Standard InChI Key:  NJGPYMFTPCLITR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5274570

    ---

Associated Targets(Human)

Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PPO2 Tyrosinase (3884 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.54Molecular Weight (Monoisotopic): 447.1947AlogP: 5.67#Rotatable Bonds: 2
Polar Surface Area: 67.97Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.59CX LogP: 5.27CX LogD: 5.26
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.43Np Likeness Score: -0.51

References

1. Elattar KM, El-Khateeb AY, Hamed SE..  (2022)  Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs.,  13  (5.0): [PMID:35694689] [10.1039/d2md00076h]

Source